Pfizer is paying $1.25 billion to join the PD-(L1)xVEGF bispecific race. | Pfizer is paying $1.25 billion to join the ...

The test may make it easier to identify whether people with memory and thinking problems have Alzheimer’s or not.

French pharma giant Sanofi SNY recently announced that it has agreed to acquire Massachusetts-based biotech Vigil ...

The FDA approved a test that can help clinicians diagnose Alzheimer's disease early on using a simple blood draw. The test ...

Analysts at BMO Capital Markets said in a weekend note that a non-invasive blood test could help boost uptake of Alzheimer’s ...

How AARP and Indeed Want to Help You Get Hired Help Register Login Login Hi, %{firstName}% Hi, %{firstName}% Games Car rental ...

Eli Lilly (NYSE:LLY) has received regulatory approval to market its Alzheimer’s therapy Kisunla (donanemab) in Australia, ...

U.S. health officials have endorsed the first blood test that can help diagnose Alzheimer’s. The test would help identify ...

A report found that the world's youngest Alzheimer's patient is actually a 19-year-old boy. He first started showing signs at ...

The test potentially makes it easier to find and treat patients with the memory-robbing disease. Read more at ...

The test has a complicated name: The Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio. But the goal of the test, created by ...